Amid disruption in Ukraine, international partnerships are preserving oncology progress—and building the foundation for long-term recovery.
By Vivek Subbiah, MD, Sarah Cannon Research Institute It is both the best of times and a challenging time...
By Ross Uhrich, DMD, MBA, ARPA-H Program Manager for POSEIDON and NITRO programs, Health Science Futures Mission Office What...
Guest post by Hisham Hamadeh, PhD, and Shawn M. Sweeney, PhD Imagine a world where many of the decisions...
By Steven Grossman, MD, PhD Pancreatic cancer is an outlier among cancers, fiercely resisting almost every scientific advance researchers...
Guest post by Raymond N. DuBois, MD, PhD, FAACR The headlines stunned many medical professionals, cancer patients, and colorectal...
Guest post by Ned Sharpless, MD, FAACR As I announced a short time ago, I have decided to step...
The most recent edition of The Cancer Letter features an op-ed from AACR President David A. Tuveson, MD, PhD,...
Guest post by Andrew T. Chan, MD One of the mechanisms by which the American Association for Cancer Research...
Guest post by Keith Hornberger, PhD The AACR-Chemistry in Cancer Research (CICR) Working Group’s mission is to advocate the...